Description
Product details
FLUTICATONE VILO 100 is a combination inhalation therapy designed to manage and control chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This formulation contains two powerful agents: Fluticasone Furoate (100 mcg), a corticosteroid that reduces inflammation in the airways, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA) that helps in bronchodilation by relaxing airway muscles. Together, they provide long-term relief from symptoms like wheezing, shortness of breath, and chest tightness. This powder is administered via inhalation, allowing targeted action directly at the site of inflammation and constriction, making it an effective and fast-acting treatment choice for those suffering from persistent asthma or airflow obstruction in COPD. What is Fluticasone Furoate and Vilanterol Powder for Inhalation? Fluticasone Furoate and Vilanterol Powder for Inhalation is a prescription medication used for long-term maintenance treatment of asthma and COPD in adults and adolescents. Fluticasone furoate is a synthetic corticosteroid that controls inflammation and swelling in the lungs. Vilanterol is a bronchodilator that improves breathing by relaxing muscles around the airways. The combination is not intended for acute bronchospasm relief but is ideal for daily use to manage chronic symptoms and prevent flare-ups. Uses of Fluticasone Furoate and Vilanterol Powder for Inhalation Long-term control of asthma symptoms such as wheezing, coughing, and breathlessness Maintenance treatment of COPD, including chronic bronchitis and emphysema Prevention of asthma exacerbations and hospitalizations Improvement in lung function and quality of life in chronic respiratory patients Regular use of this inhaler can help reduce dependency on rescue inhalers and lower the frequency of asthma attacks or COPD exacerbations. Fluticasone Furoate and Vilanterol Powder for Inhalation Side Effects While generally well-tolerated, some users may experience mild to moderate side effects including: Headache Throat irritation Hoarseness of voice Oral thrush (fungal infection in the mouth) Cough or upper respiratory tract infections Increased heart rate or palpitations Muscle cramps or tremors Rare allergic reactions like rash, itching, or swelling To minimize the risk of oral thrush, it is advised to rinse the mouth thoroughly after each inhalation. Precautions Before Using FLUTICATONE VILO 100 Do not use it to treat sudden asthma attacks; it is not a rescue inhaler. Inform your doctor if you have a history of heart disease, high blood pressure, diabetes, or liver problems. Use with caution in pregnancy and breastfeeding; consult your physician. Regular monitoring of lung function and adrenal activity is recommended during long-term use. Children and adolescents may require special dose adjustments under medical supervision. Drug Interactions: What Drugs Interact with Fluticasone Furoate and Vilanterol? Several medications may interact with this combination and alter its effectiveness or increase the risk of side effects: Beta-blockers (e.g., propranolol): May reduce the bronchodilatory effect of vilanterol Ketoconazole or Ritonavir: These strong CYP3A4 inhibitors can increase the levels of fluticasone in the blood, raising the risk of side effects Diuretics: May increase the risk of hypokalemia when used with vilanterol Other corticosteroids: Concurrent use may enhance systemic corticosteroid side effects MAO inhibitors and Tricyclic Antidepressants: May amplify cardiovascular effects Always inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting FLUTICATONE VILO 100. Conclusion FLUTICATONE VILO 100 is a scientifically advanced, dual-action inhalation therapy that provides effective long-term control for asthma and COPD. With the anti-inflammatory strength of fluticasone furoate 100 mcg and the bronchodilating effect of vilanterol 25 mcg, this combination ensures better breathing, fewer flare-ups, and improved quality of life. It’s a reliable and essential component in the chronic respiratory care of patients who need consistent symptom control and lung function improvement.
